FDA granted accelerated approval to Mirati’s KRAS drug adagrasib, which will be marketed as Krazati. The greenlight comes two days ahead of the expected decision and cements the biotech as the second in the KRAS field behind leader Amgen, maker of the May, 2021-approved Lumakras. The nod is for second-line…
...
News Ticker
- [ February 3, 2023 ] Postdoctoral Fellow – Computational Biology, Computational Chemistry, Bioinformatics – City of Hope – Duarte, CA Los Angeles Biotech Jobs
- [ February 3, 2023 ] Research Associate – AdvanBio – Irvine, CA Los Angeles Biotech Jobs
- [ February 3, 2023 ] Staff Research Associate I – Biological Chemistry – UCLA Health – Los Angeles, CA Los Angeles Biotech Jobs
- [ February 3, 2023 ] Laboratory Director – Somatic Curation – Fulgent Therapeutics Llc – El Monte, CA Los Angeles Biotech Jobs
- [ February 2, 2023 ] Director, Regulatory Affairs CMC – Cell Therapy – Kite Pharma – Santa Monica, CA Los Angeles Biotech Jobs
Copyright © 2021 Biotech Networks, LLC
